Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by itntdf


T.ONC

RE:RE:RE:RE:RE:RE:RE:New Press Release - Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

he appears in the "investment track" acadia room in the 10:30-11...

February 28, 2024

T.ONC

RE:RE:RE:New Press Release - Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

maybe the most charitable spin on this would be the ability to converse with...

February 28, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:Very strange , even for ONC

if, as you say, onc is a bad investment, then what difference does it make if...

February 27, 2024

T.ONC

Last PR still showed a San Diego Byline

Well, if oncy is still entertaining a new office space in the San Diego area...

February 22, 2024

T.ONC

RE:RE:RE:Irinotecan

https://www.cell.com/molecular-therapy-family/oncology/fulltext/S2372-7705(23...

February 16, 2024

T.ONC

RE:Hold tight folks

yeah, my knuckles are white.  this is from a news release that's...

February 13, 2024

T.ONC

RE:Hold tight folks

any link for this "news"?

February 13, 2024

T.ONC

RE:RE:Spontaneous tumor regression following COVID-19 vaccination

guess someone should let them know about pela: Challenges remain to select...

January 29, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:CG Oncology

or more precisely, successfully using an approved fda surrogate enpoint...

January 26, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:CG Oncology

using fda approved surrogate endpoints.

January 26, 2024

T.ONC

RE:some color behind pancan strategic reevaluation

The relationship between PanCAN and GCAR spans many years, as GCAR’s CEO, Dr....

January 18, 2024

T.ONC

some color behind pancan strategic reevaluation

After four years of operation, PanCAN underwent a strategic re-evaluation of...

January 18, 2024

T.ONC

reo and t cell-based strategies

Cancer Immunol Res   ...

January 17, 2024

T.ONC

RE:2024 deadline

you didn't specify what year.

January 17, 2024

T.ONC

RE:RE:RE:RE:EU approves first I/O combination

pela is not a standalone (yet) but it has been shown, when used first in a...

January 16, 2024

T.ONC

RE:RE:RE:open for business

andrew's wife has a number of companies which could be considered...

January 16, 2024

T.ONC

open for business

Business Development Consultant Andrew de Guttadauro Consulting, LLC &...

January 16, 2024

T.ONC

RE:RE:Something cooking or is retail playing “follow the leader “?

The United States is the world's largest economy, ahead of China, and...

January 9, 2024

T.ONC

shareholder interaction 101, note taking, not a doormat

Sent: Friday, January 5, 2024 9:44 AM To: Matt Coffey  Subject...

January 5, 2024

T.ONC

RE:RE:RE:San Diego

over the years i have emailed both brad and matt and have gotten responses...

January 4, 2024

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next

Featured Company